Vanita Noronha
A medical oncologist who co-leads Tata Memorial's lung cancer trials and built India's geriatric oncology programme.
Vanita Noronha co-led the gefitinib-plus-chemotherapy trial in EGFR-mutant lung cancer and established a geriatric oncology clinic and research programme at Tata Memorial.
| Title | Journal | Year |
|---|---|---|
| Gefitinib versus gefitinib plus pemetrexed and carboplatin chemotherapy in EGFR-mutated lung cancer | Journal of Clinical Oncology | 2020 |
Pages like this
not linked directly; found by shared links- IdeaCommunity health workers with smartphone AI screen for mouth cancer in South Asia
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
- PersonPankaj Chaturvedi
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
- PersonKumar Prabhash
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- IdeaValidate low-cost metronomic oral regimens in phase 3 and carry them into guidelines
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
- PersonHye Ryun Kim
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- PersonVijay Patil
Shares Tata Memorial Centre, Head and neck squamous cell carcinoma.
- IdeaProtect hearing from cisplatin in adults as we now do in children
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.
- PersonCharu Aggarwal
Shares Head and neck squamous cell carcinoma, Non-small-cell lung cancer.